Healthy high growth potential

Results

24

1 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

24 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
RHM
€1,205.600.5%-31.5%€56.1b€1,889.3853.430.8%1.0%Capital Goods
4X0
€33.36-4.9%-33.8%€173.5m€58.0044.750.7%0.7%Capital Goods
LIK
€510.00-1.0%44.9%€152.0m€647.5026.735.7%n/aHealthcare
OHB
€410.509.2%443.0%€7.9b€320.00140.136.6%0.1%Capital Goods
V1NC
€16.20-4.6%n/a€810.0m€22.9041.923.4%n/aCapital Goods
R3NK
€46.21-10.9%-35.3%€4.6b€68.1440.224.4%1.3%Capital Goods
LPK
€22.808.1%176.7%€557.6m€15.504.9106.1%0%Tech
Y73
€1.580.6%-59.0%€98.2mn/a20.331.5%n/aCapital Goods
LMIA
€2.180%74.4%€27.0m€3.2011.732.8%n/aCapital Goods
ELB
New
€1.62-6.9%-22.9%€9.6m€2.600.2139.9%n/aConsumer Durables
YSN
€183.20-9.3%-12.3%€1.2b€239.6739.720.8%1.4%Software
NF4
€76.720%80.1%€179.0m€72.6352.227.4%0.5%Diversified Financials
2GB
€63.50-5.4%97.2%€1.1b€65.0046.526.5%0.3%Capital Goods
NN6
€1.770%7.6%€22.3m€4.404.380.1%0%Healthcare
HAG
€75.62-2.8%-18.8%€8.7b€90.9787.330.8%0.7%Capital Goods
1INN
€79.60-5.1%-7.0%€796.0m€212.0615.919.8%5.0%Software
HIGH
€6.22-0.3%-4.3%€77.6m€10.00613.456.2%n/aPharmaceuticals & Biotech
CHG
€31.30-1.3%-26.9%€746.3m€46.004.173.3%n/aDiversified Financials
IXX
€52.703.1%32.4%€523.4m€66.6723.623.0%1.5%Software
PSAN
€45.300%58.9%€701.6m€45.002.4109.7%0%Software
IBU
€17.350.9%168.6%€82.4m€25.0014438.175.9%0.7%Materials
FYB
€20.552.2%-25.3%€363.2m€39.866.9120.7%n/aPharmaceuticals & Biotech
ENR
€153.58-2.6%73.1%€131.4b€195.0859.026.3%0.5%Capital Goods
YOC
€7.046.0%-51.9%€24.5m€15.000.664.5%n/aMedia
Page 1 of 1